Metformin for non- diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial. Lancet Diab Endocrinol 2014; 2: 116-124.Preiss D, Lloyd SM, Ford I, et al. Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised ...
Metformin is noted for its beneficial effects on lifespan extension and on disorders due to increased insulin resistance. Further investigations, including randomized control trials in nondiabetic individuals, are required to demonstrate the nonglycemic effects of metformin. 展开 关键词:...
Despite the fact that its precise mechanism of action it is not completely elucidated, long-term treatment with this drug in monotherapy, improves glycaemic control and reduces cardiovascular mortality in overweight type 2 diabetic patients. Experimental evidence produced over the years suggests that ...
Can the use of metformin in non-diabetic obese pregnant women reduce maternal-fetal obstetric outcomes? Methods A systematic review of the literature was performed using the PRISMA checklist, and for bias investigation an adaptation of the Downs and Black scale was organized. Research from randomized...
In such patients with metformin intolerance, some experts suggest initiation of therapy with 2 drugs from other antidiabetic drug classes with complementary mechanisms of action.Consider early initiation of combination therapy for the treatment of type 2 diabetes mellitus to extend the time to treatment...
Besides medications, other dietary factors such as fruit and vegetable consumption in diabetic patients could also be strong independent determinants of homocysteine levels [39]. Recent studies show that lowering homocysteine levels does not decrease the risk for atherosclerosis or thrombosis [40, 41]....
Metformin Prevents the Progression of Dysplastic Mucosa of the Head and Neck to Carcinoma in Nondiabetic Patients 来自 掌桥科研 喜欢 0 阅读量: 10 作者: Lerner, Michael ZviMor, NivPaek, HyungBlitzer, AndrewStrome, Marshall 摘要: Objective: Metformin is an oral anti-hyperglycemic agent used ...
The impact of metformin on weight and metabolic parameters in patients with obesity: A systematic review and meta‐analysis of randomized controlled trials There are conflicting data on the weight‐reducing potential of metformin (MTF) in nondiabetic patients with obesity. The purpose of this systemat...
Glucophage with the active ingredient metformin is a medication, used by diabetes patients of the 2nd type to control the levels of sugar in blood.
Similar results were obtained for the somatic component of MLHFQ whereas no association of MET treatment with emotional component of the MLHFQ score was found (data not shown). Diabetes treatment and outcome Kaplan–Meier analysis showed that MET-treated diabetic patients had better survival compared ...